4FW8 image
Deposition Date 2012-06-30
Release Date 2012-11-28
Last Version Date 2024-03-20
Entry Detail
PDB ID:
4FW8
Keywords:
Title:
Crystal structure of FABG4 complexed with Coenzyme NADH
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.79 Å
R-Value Free:
0.23
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:3-oxoacyl-(Acyl-carrier-protein) reductase
Gene (Uniprot):fabG-1
Chain IDs:A, B, C, D
Chain Length:454
Number of Molecules:4
Biological Source:MYCOBACTERIUM TUBERCULOSIS
Primary Citation
Crystal structure of hexanoyl-CoA bound to beta-ketoacyl reductase FabG4 of Mycobacterium tuberculosis
Biochem.J. 450 127 139 (2013)
PMID: 23163771 DOI: 10.1042/BJ20121107

Abstact

FabGs, or β-oxoacyl reductases, are involved in fatty acid synthesis. The reaction entails NADPH/NADH-mediated conversion of β-oxoacyl-ACP (acyl-carrier protein) into β-hydroxyacyl-ACP. HMwFabGs (high-molecular-weight FabG) form a phylogenetically separate group of FabG enzymes. FabG4, an HMwFabG from Mycobacterium tuberculosis, contains two distinct domains, an N-terminal 'flavodoxintype' domain and a C-terminal oxoreductase domain. The catalytically active C-terminal domain utilizes NADH to reduce β-oxoacyl-CoA to β-hydroxyacyl-CoA. In the present study the crystal structures of the FabG4-NADH binary complex and the FabG4-NAD+-hexanoyl-CoA ternary complex have been determined to understand the substrate specificity and catalytic mechanism of FabG4. This is the first report to demonstrate how FabG4 interacts with its coenzyme NADH and hexanoyl-CoA that mimics an elongating fattyacyl chain covalently linked with CoA. Structural analysis shows that the binding of hexanoyl-CoA within the active site cavity of FabG significantly differs from that of the C16 fattyacyl substrate bound to mycobacterial FabI [InhA (enoyl-ACP reductase)]. The ternary complex reveals that both loop I and loop II interact with the phosphopantetheine moiety of CoA or ACP to align the covalently linked fattyacyl substrate near the active site. Structural data ACP inhibition studies indicate that FabG4 can accept both CoA- and ACP-based fattyacyl substrates. We have also shown that in the FabG4 dimer Arg146 and Arg445 of one monomer interact with the C-terminus of the second monomer to play pivotal role in substrate association and catalysis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures